| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/16/2010 | US7662936 Mass spectrometry of antibody conjugates |
| 02/16/2010 | US7662933 Pegylated granulocyte colony stimulating factor (G-CSF) to treat a hematopoietic disorder related to reduced neutrophil count, such as infectious disease, sepsis, or a result of radiotherapy or chemotherapy |
| 02/16/2010 | US7662932 Endothelial growth factor; isolated polypeptide; stimulate cell proliferation, neovascularization, vascular system permeability |
| 02/16/2010 | US7662931 immunoglobulin domain peptides having myostatin, erythropoietin or thrombopoietin peptides as an internal sequence, preferably in a loop region of the domain; antibodies |
| 02/16/2010 | US7662930 Polishing steps used in multi-step protein purification processes |
| 02/16/2010 | US7662929 Enzyme is a drug target; cancer, inflammatory diseases such as psoriasis |
| 02/16/2010 | US7662928 Anti-FcRn antibodies for treatment of auto/allo immune conditions |
| 02/16/2010 | US7662927 Reducing viral infections and increasing monocyte counts; hybridomas expressing monoclonal antibodies |
| 02/16/2010 | US7662926 Selectively bind human FcyRIIB, with little or no binding to other human Fc gamma Rs, e.g., human Fc gamma RIIA; atherosclerosis; leukocyte adhesion deficiency; rheumatoid arthritis; systemic lupus erythematosus (SLE); diabetes mellitus; multiple sclerosis; Reynaud's syndrome; autoimmune thyroiditis; |
| 02/16/2010 | US7662925 Optimized Fc variants and methods for their generation |
| 02/16/2010 | US7662922 Canola protein isolate compositions |
| 02/16/2010 | US7662641 using the antibodies to detect the presence of the protein; Zven is a human protein expressed in testicular tissue and peripheral blood lymphocytes; stimulate gastrointestinal contractility, gastric emptying, intestinal transit, and treating gastroparesis; may also inhibit Wnt gene; lung tumors |
| 02/16/2010 | US7662633 Method of screening for inhibitors of osteopontin |
| 02/16/2010 | US7662623 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site |
| 02/16/2010 | US7662620 Stem cell-derived neuron survival factor polypeptides (SDNSF) for use in prevention and treatment of cell proliferative, neurodegenerative and cardiovascular disorders |
| 02/16/2010 | US7662557 Methods for producing members of specific binding pairs |
| 02/16/2010 | US7662548 Method of screening for modulators of HIV infection |
| 02/16/2010 | US7662399 BASB054 polypeptides |
| 02/16/2010 | US7662398 Microorganisms for therapy |
| 02/16/2010 | US7662394 Nucleic acids encoding chimeric Flavivirus immunogens comprising the Japanese encephalitis virus (JEV) PRM signal sequence |
| 02/16/2010 | US7662392 Stromal-Derived Factor-1 (SDF), G-CSF (granulocyte-colony stimulating factor), stimulating vasculogenesis; improves cardiac function |
| 02/16/2010 | US7662391 Polynucleotide sequence for Chalmydia pneumonia; therapy, prevention of Chlamydia infections ; vaccines |
| 02/16/2010 | US7662387 administering a conjugate of antibody ( humanized, chimeric or constant region) and a drug such as fetoprotein/alpha-/, monomethyl auristatin E or monomethyl auristatin F to treat CD70-expressing cancer selected from a kidney tumor, a B cell lymphoma, a thymic carcinoma, and a nasopharyngeal carcinoma |
| 02/16/2010 | US7662384 Use of anti-α5β1 antibodies to inhibit cancer cell proliferation |
| 02/16/2010 | US7662383 Epitope bound by MAbs A, B, C or D, where MAbs A, B, C and D have given variable domains; chimeric or humanized for side effect reduction; polymerase chain reaction |
| 02/16/2010 | US7662382 Inducible ligand for α1β1 integrin and uses |
| 02/16/2010 | US7662380 ZAQ ligand-1 antibodies and uses thereof |
| 02/16/2010 | US7662379 Interleukin-10 antibodies |
| 02/16/2010 | US7662378 administering anti-CEA (carcinogenicembryonic antigen) monoclonal antibody (MAb) or fragment and a drug selected from vincristine, doxorubicin, dacarbazine (DTIC), cyclophosphamide, CPT-11, oxaliplatin, gemcitabine and 5-fluorouracil/leucovorin |
| 02/16/2010 | US7662377 Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof |
| 02/16/2010 | US7662376 sterol transporter polypeptide for use in the treatment of hypercholesterolemia, hyperlipidemia, gall stones, and atherosclerosis; monoclonal or polyclonal antibody or fab or fv fragments that specifically binds the polypeptide having specific amino acid sequence |
| 02/16/2010 | US7662374 Dual-specificity antibody having specificity for both an activated erbB2 receptor and erbB1 dimers, without significant affinity for monomeric EGFr that is not activate; specificity of the antibodies is due to their recognition and binding of activation epitopes; diagnosis, imaging and for treating tumor |
| 02/16/2010 | CA2223701C Fgf9 as a specific ligand for fgfr3 |
| 02/16/2010 | CA2177612C Nucleic acids encoding a house dust mite allergen, der p iii, and uses therefor |
| 02/13/2010 | CA2638651A1 Antibody-based protein microarray to detect long-term stress in animal tissues |
| 02/11/2010 | WO2010017468A1 Treatment of autoimmune and inflammatory disease |
| 02/11/2010 | WO2010017332A2 Radioprotectants targeting thrombospondin-1 and cd47 |
| 02/11/2010 | WO2010017103A2 Fully human anti-human nkg2d monoclonal antibodies |
| 02/11/2010 | WO2010017089A1 Methods for detecting symmetrical demethylarginine |
| 02/11/2010 | WO2010017086A1 Effectors of par-2 activation and their use in the modulation of inflammation |
| 02/11/2010 | WO2010017070A1 Anti-hepcidin-25 selective antibodies and uses thereof |
| 02/11/2010 | WO2010016760A2 Immunogenic composition for the treatment of bacterial infection |
| 02/11/2010 | WO2010016652A1 Antibody modulating the differentiation and function of dendritic cells via binding intercellular adhesion molecule-1 and use thereof |
| 02/11/2010 | WO2010016533A1 Method for obtaining purkinje progenitor cell by using neph3(65b13) and e-cadherin |
| 02/11/2010 | WO2010016526A1 Pharmaceutical composition for treatment and prevention of cancer |
| 02/11/2010 | WO2010015834A1 Antibodies specific for misfolded proteins and methods for their production |
| 02/11/2010 | WO2010015705A1 Pharmaceutical compositions comprising antibodies binding to the intracellular domain of ebv (epstein-barr virus) latent membrane protein-1 (lmp1) |
| 02/11/2010 | WO2010015683A1 Mannose-6-phosphate-binding antibodies and their uses |
| 02/11/2010 | WO2010015608A1 Compositions and methods for antibodies targeting complement protein c5 |
| 02/11/2010 | WO2010015264A1 L-asparaginase from helicobacter pylori |
| 02/11/2010 | WO2009054873A4 Anti-rantes antibodies and methods of use thereof |
| 02/11/2010 | US20100037355 Sequence-determined dna fragments and corresponding polypeptides encoded thereby |
| 02/11/2010 | US20100037352 Sequence-determined dna fragments and corresponding polypeptides encoded thereby |
| 02/11/2010 | US20100036102 Novel chelating agents and highly luminescent and stable chelates and their use |
| 02/11/2010 | US20100036101 Antibodies against non functional p2x7 receptor |
| 02/11/2010 | US20100036100 T cell proteins and nucleotides encoding the same |
| 02/11/2010 | US20100036091 Antibody-based diagnostics and therapeutics |
| 02/11/2010 | US20100035339 Human diacylglycerol acyltransferase 2 (dgat2) family members and uses therefor |
| 02/11/2010 | US20100035299 Methods for the purification of polypeptide conjugates |
| 02/11/2010 | US20100035289 Diagnosis and risk stratification by means of the novel marker ct-proadm |
| 02/11/2010 | US20100035281 Compositions and methods for tissue-based protein truncation test for disease diagnosis |
| 02/11/2010 | US20100035274 Methods for Detecting Symmetrical Dimethylarginine |
| 02/11/2010 | US20100035270 Methods and Compositions for the Detection of Bovine Pregnancy |
| 02/11/2010 | US20100035241 Isolation Of Allergen-Specific Immunoglobulin Genes From Human B-Cells From Atopy Sufferers |
| 02/11/2010 | US20100034846 Novel method for treating h.pylori infections |
| 02/11/2010 | US20100034841 Antigenic polypeptide usable as therapeutic agent for malignant neoplasm |
| 02/11/2010 | US20100034837 Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds |
| 02/11/2010 | US20100034836 Compositions and methods for the diagnosis and alleviation of tumor |
| 02/11/2010 | US20100034834 Modified t cell receptors and related materials and methods |
| 02/11/2010 | US20100034833 High affinity human antibodies to human il-18 receptor |
| 02/11/2010 | US20100034831 Agents that Bind a Target in Pulmonary Tissue for Targeting Respiratory Diseases |
| 02/11/2010 | US20100034828 Method of Increasing Radiation Sensitivity by Inhibition of Beta One Integrin |
| 02/11/2010 | US20100034826 Human monoclonal antibodies to protein tyrosine kinase 7 (ptk7) and methods for using anti-ptk7 antibodies |
| 02/11/2010 | US20100034825 Generation of a cancer-specific immune response toward muc1 and cancer specific muc1 antibodies |
| 02/11/2010 | US20100034823 Crystalline anti-hTNFalpha antibodies |
| 02/11/2010 | US20100034822 Haemophilus Influenzae Type B |
| 02/11/2010 | US20100034820 Binding domain-immunoglobulin fusion proteins |
| 02/11/2010 | US20100034814 Compositions and methods for binding lysophosphatidic acid |
| 02/11/2010 | US20100034812 Antibodies Specific for BET V1 and Use Thereof in the Prevention and Treatment of BET V1- Induced Diseases |
| 02/11/2010 | US20100034809 Compositions and Methods for Antibodies Targeting Complement Protein C5 |
| 02/11/2010 | US20100034780 Tumor antigen peptide derived from amacr |
| 02/11/2010 | CA2733529A1 Antibody modulating the differentiation and function of dendritic cells via binding intercellular adhesion molecule-1 and use thereof |
| 02/11/2010 | CA2733497A1 Anti-hepcidin-25 selective antibodies and uses thereof |
| 02/11/2010 | CA2733432A1 Treatment of autoimmune and inflammatory disease |
| 02/11/2010 | CA2733223A1 Pharmaceutical composition for treatment and prevention of cancers |
| 02/11/2010 | CA2733075A1 Monoclonal antibodies against tissue factor pathway inhibitor (tfpi) |
| 02/11/2010 | CA2733041A1 Effectors of par-2 activation and their use in the modulation of inflammation |
| 02/11/2010 | CA2732782A1 Compositions and methods for antibodies targeting complement protein c5 |
| 02/11/2010 | CA2732102A1 Radioprotectants targeting thrombospondin-1 and cd47 |
| 02/11/2010 | CA2731438A1 Anti-pancreatic cancer antibodies |
| 02/10/2010 | EP2151687A1 Mannose-6-phosphate-binding antibodies and their uses |
| 02/10/2010 | EP2151507A1 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
| 02/10/2010 | EP2151493A1 Host cells containing multiple integrating vectors |
| 02/10/2010 | EP2151454A2 Platelet-derived growth factor D, DNA coding therefor, and uses thereof |
| 02/10/2010 | EP2151244A1 Compositions and methods for the diagnosis and treatment of tumor |
| 02/10/2010 | EP2150817A1 Methods for reducing viral load in hiv-1-infected patients |
| 02/10/2010 | EP2150564A2 Antagonists to il-17a, il-17f, and il-23p19 and methods of use |
| 02/10/2010 | EP2150563A1 HUMANIZED ANTIBODIES TO Aß(20-42) GLOBULOMER AND USES THEREOF |
| 02/10/2010 | EP2150276A1 Antibodies binding to an intracellular prl-1 or prl-3 polypeptide |
| 02/10/2010 | EP1700119B1 Beta-lactamase cd4+ t-cell epitopes |